基于核酸适配子W3量子点探针的转移性大肠癌靶向成像

目的核酸适配子W3偶联量子点QD605制备特异性探针(W3-QD),并对大肠癌细胞以及临床大肠癌组织石蜡切片标本进行靶向成像。方法荧光显微镜分析W3-QD对混合培养细胞中靶细胞LoVo的特异性识别能力;利用W3-QD对不同种类细胞进行特异性成像并扫描定量,同时利用流式细胞术对其进行验证;进一步利用W3-QD对临床大肠癌患者组织标本进行特异性成像。结果 W3-QD能够特异性识别混合细胞培养中的LoVo细胞,并能够对不同种类的细胞进行定量成像,与流式细胞术的结果一致;将W3-QD进一步用于临床患者组织标本上,能对转移性大肠癌患者的癌组织进行靶向成像作用。结论核酸适配子-量子点(W3-QD)探针荧光检测技术可应用于转移性大肠癌患者癌组织的靶向成像。     

以双歧杆菌为载体实现量子点在体靶向肿瘤的可行性研究

应用双歧双歧杆菌作为量子点输送载体,为小动物在体生物肿瘤成像提供依据. 采用电穿孔方法,将
二棕榈酰磷脂酰胆碱（DPPC）包被的硫硒镉水溶性量子点转入细菌内,得到“量子点-细菌”复合探针,在
“量子点-细菌”表面通过1-(3-二甲氨基丙基)-3-乙基碳二亚胺 (EDC)活化法进一步偶联叶酸分子,制得
“量子点-细菌-叶酸”复合纳米生物探针. 将纳米生物探针经尾静脉注入Lewis肺癌小鼠体内,采用冰冻组
织切片,考察探针在小鼠体内脏器及肿瘤的分布情况. 结果表明,在肿瘤部位检测到较强的量子点光致发光
信号,而在肺、肝、脾等脏器中只检测到微弱的量子点发光信号. “量子点-细菌-叶酸”复合纳米生物探
针小动物在体肿瘤靶向成像是可行的.     

高灵敏荧光探针用于肿瘤 Ramos 细胞的快速检测

本文以聚苯乙烯纳米微球为载体,基于适体特异性识别和 DNA 杂交原理,组装了一种 DNA-CdTe 量子点纳米线,制备了具有较高荧光强度的复合型荧光探针,并成功用于 Ramos 细胞的荧光成像。该探针可以用于特异性识别肿瘤细胞,在荧光成像中信号强灵敏度高,为肿瘤细胞的检测提供一种新方法。     

高灵敏荧光探针用于肿瘤Ramos细胞的快速检测

本文以聚苯乙烯纳米微球为载体,基于适体特异性识别和DNA杂交原理,组装了一种DNA-CdTe量子点纳米线,制备了具有较高荧光强度的复合型荧光探针,并成功用于Ramos细胞的荧光成像。该探针可以用于特异性识别肿瘤细胞,在荧光成像中信号强灵敏度高,为肿瘤细胞的检测提供一种新方法。     

胃癌血管靶向肽GX1修饰的人血清白蛋白用于胃癌近红外活体成像

目的:以肿瘤血管靶向肽GX1修饰的人血清白蛋白(HSA)作为吲哚菁绿(ICG)的载体,合成近红外荧光探针GX1-HSA-ICG,研究其作为近红外荧光探针在荷人胃癌裸鼠活体中的靶向成像能力。方法:以HSA作为ICG的载体,通过化学修饰与GX1共价连接,合成GX1-HSA-ICG纳米颗粒探针;使用SDS-PAGE对探针合成进行鉴定;采用探针与脐静脉内皮细胞HUVEC以及与肿瘤细胞共培养的脐静脉内皮细胞Co-HUVEC进行结合和竞争抑制试验,验证探针和Co-HUVEC细胞结合的特异性;利用小动物活体成像系统对皮下荷胃癌小鼠进行近红外荧光活体成像,验证探针在体内的胃癌靶向性。结果:成功合成GX1-HSA-ICG。细胞结合与竞争抑制实验显示GX1-HSA-ICG可与Co-HUVEC细胞特异性结合;荷瘤小鼠活体成像也显示出GX1-HSA-ICG较ICG有更长体内的循环时间,并且胃癌组织局部较HSA-ICG有更强的聚集。结论:本研究成功合成了胃癌血管靶向肽GX1修饰的HSA为荧光染料载体的胃癌血管靶向探针,成功对荷胃癌裸鼠进行了活体成像。使用HSA为载体的探针较单纯使用ICG的肿瘤局部滞留能力显著提高,GX1增加了探针的胃癌靶向特异性。该探针在胃癌的早期诊断和抗肿瘤血管生成治疗评估中具有潜在的应用价值。     

量子点制备和表征及标记黄曲霉毒素B1性能分析

用碲粉、水合氯化镉和巯基丙酸在水相中合成了发光量子点碲化镉纳米晶标记物,通过TEM和荧光分光光度计对其进行表征;CdTe量子点与羊抗兔IgG相连接,对其进行电泳表征,此复合物即为荧光显示探针。将人工抗原AFB1-BSA包被于96微孔板上,黄曲霉毒素B1（AFB1）为模式分析物,与黄曲霉毒素单克隆抗体发生竞争反应。之后用荧光显示探针与AFB1单克隆抗体进行特异性免疫,以量子点探针的荧光强度定量测定AFB1。在适宜试验条件下,AFB1浓度在1~1 000 ng/mL范围内,荧光强度与AFB1含量成线性关系,检出限为1ng/mL。     

米糠蛋白的提取及其在食品领域中的应用

基于共价结合原理,以CdTe量子点和介孔二氧化硅为基础,设计和制备了DNA-CdTe/介孔二氧化硅荧光探针.CdTe量子点具有较强的荧光性能,所用DNA适体链是Ramos细胞的识别序列,所以此探针可特异性识别Ramos细胞,并用于激光共聚焦显微镜对Ramos细胞的荧光成像.本工作为肿瘤细胞的早期诊断提供了一定的理论依据.     

量子点荧光标记技术的研究热点及面临的挑战

半导体量子点作为新型荧光标记物,在生物医学领域具有重要应用．与传统的有机染料及荧光蛋白等荧光标记物相比,半导体量子点具有发光颜色可调、激发范围宽、发射光谱窄、化学及光稳定性好、表面化学丰富以及生物偶联技术成熟等诸多优势,为生命体系的靶向示踪,高灵敏、原位、实时、动态荧光成像,DNA及蛋白质检测,靶向药物,临床医学,生物芯片和传感器等研究提供了新的发展契机．基于作者在半导体量子点生物荧光成像和安全性评价研究的基础,综述了半导体量子点荧光标记物在生命科学与医学领域应用的研究热点,并对半导体量子点荧光标记技术走向实用面临的挑战进行了评述．     

脂质体包裹阿霉素的体外抗肿瘤作用

 我们用超声法制备了内部包裹阿霉素,表面有抗人胃癌细胞M85的单克隆抗体3Hll或非相关抗体IgG的阿霉素靶向脂质体和阿霉素非靶向脂质体,研究了这些脂质体和游离阿霉素抑制靶细胞M85和非靶细胞HeLa细胞生长的能力。结果表明,一方面,与游离阿霉素或阿霉素非靶向脂质体相比,阿霉素靶向脂质体抑制M85细胞生长的能力提高了2—4倍,而在抑制非靶细胞HeLa细胞的生长方面,阿霉素靶向脂质体的效力还不如游离阿霉素或阿霉素非靶向脂质体。过量的游离单克隆抗体3Hll可以有效地抑制阿霉素靶向脂质体对M85细胞的细胞毒作用,而另一种单克隆抗体3G9则不能。空靶向和空非靶向脂质体对M85细胞生长均无影响。因此,靶向脂质体可以把包裹的抗癌药物专一地送给胃癌细胞,井杀伤它们。     

多序列比对的量子点荧光探针检测金黄色葡萄球菌的研究

利用以量子点（Quantum dot,QD）作为供体、有机荧光染料作为受体的荧光能量共振转移（Fluores—cence resonance energy transfer,FRET）体系检测核酸等大分子是一种非常重要的检测手段。本文构建了一种检测金黄色葡萄球菌种特异性16SrDNA的新方法。此方法以羧基修饰的525nm量子点与氨基修饰的DNA在EDC的作用下通过脱水连接形成QD—DNA复合物作为荧光能量共振转移体系的供体、有机荧光基团ROX修饰的DNA作为荧光能量共振转移体系的受体组成能与金黄色葡萄球菌种特异性16SrDNA杂交的检测探针。当探针与靶序列发生杂交时,作为供体的525nmQD与作为受体的ROX之间的距离被缩短至能有效发生荧光能量共振转移的距离之内。此时,以不能致ROX发光的波长激发量子点发光,其荧光强度下降,而ROX的荧光强度上升。在不存在靶序列的情况下,不会发生这种荧光强度的变化。QD与ROX荧光强度的变化是实现本检测体系快速、简单的重要保证。     

Dual‐function fluorescent probe for cancer imaging and therapy

To date, several fluorescent probes modified by a single targeting agent have been explored. However, studies on the preparation of dual‐function quantum dot (QD) fluorescent probes with dual‐targeting action and a therapeutic effect are rare. Here, a dual‐targeting CdTe/CdS QD fluorescent probe with a bovine serum albumin–glycyrrhetinic acid conjugate and arginine‐glycine‐aspartic acid was successfully prepared that could induce the apoptosis of liver cancer cells and showed enhanced targeting in in vitro cell imaging. Therefore, the as‐prepared fluorescent probe in this work is an efficient diagnostic tool for the simultaneous detection of liver cancer and breast cancer cells. Copyright © 2015 John Wiley & Sons, Ltd.     

Near-infrared fluorescence-labeled anti-PD-L1-mAb for tumor imaging in human colorectal cancer xenografted mice

The expression of programmed death ligand-1 (PD-L1) in tumor has been used as a biomarker to predict the anti-PD-L1 immunotherapy response. To develop a noninvasive imaging technique to monitor the dynamic changes in PD-L1 expression in colorectal cancer (CRC), we labeled an anti-PD-L1 monoclonal antibody with near-infrared (NIR) dye and tested the ability of the NIR-PD-L1-mAb probe to monitor the PD-L1 expression in CRC-xenografted mice by performing optical imaging. Consistent with the expression levels of PD-L1 protein in three CRC cell lines in vitro by flow cytometry and Western blot analyses, our in vivo imaging showed the highest fluorescence signal of the xenografted tumors in mice bearing SW620 CRC cells, followed by tumors derived from SW480 and HCT8 cell lines. We detected the highest fluorescent intensity of the tumor at 120 hours after injection of NIR-PD-L1-mAb. The highest fluorescence intensity was seen in the tumor, followed by the spleen and the liver in SW620 xenografted mice. In SW480 and HCT8 xenografted mice, however, the highest fluorescent signals were detected in the spleen, followed by the liver and the tumor. Our findings indicate that SW620 cells express a higher level of PD-L1, and the NIR-PD-L1-mAb binding to PD-L1 on the surface of CRC cells was specific. The technique was safe and could provide valuable information on PD-L1 expression of the tumor for development of a therapeutic strategy of personized targeted immunotherapies as well as treatment response of patients with CRC.     

An antibody-conjugated internalizing quantum dot suitable for long-term live imaging of cells.

Quantum dots (QD) are fluorescent semiconductor nanocrystals that are emerging as superior alternatives to the conventional organic dyes used in biological applications. Although QDs offer several advantages over conventional fluorescent dyes, including greater photostability and a wider range of excitation and (or) emission wavelengths, their toxicity has been an issue in its wider use as an analytic, diagnostic and therapeutic tool. We prepared a conjugate QD with an internalizing antibody and demonstrated that the QD-antibody conjugate is efficiently internalized into cells and is visible even after multiple divisions. We demonstrate that the internalized QD is nontoxic to cells and provides a sensitive tool for long-term molecular imaging.     

A comparison of the emission efficiency of four common green fluorescence dyes after internalization into cancer cells

In vivo optical imaging to enhance the detection of cancer during endoscopy or surgery requires a targeted fluorescent probe with high emission efficiency and high signal-to-background ratio. One strategy to accurately detect cancers is to have the fluorophore internalize within the cancer cells permitting nonbound fluorophores to be washed away or absorbed. The choice of fluorophores for this task must be carefully considered. For depth of penetration, near-infrared probes are ordinarily preferred but suffer from relatively low quantum efficiency. Although green fluorescent protein has been widely used to image tumors on internal organs in mice, green fluorescent probes are better suited for imaging the superficial tissues because of the short penetration distance of green light in tissue and the highly efficient production of signal. While the fluorescence properties of green fluorophores are well-known in vitro, less attention has been paid to their fluorescence once they are internalized within cells. In this study, the emission efficiency after cellular internalization of four common green fluorophores conjugated to avidin (Av-fluorescein, Av-Oregon green, Av-BODIPY-FL, and Av-rhodamine green) were compared after each conjugate was incubated with SHIN3 ovarian cancer cells. Using the lectin binding receptor system, the avidin-fluorophore conjugates were endocytosed, and their fluorescence was evaluated with fluorescence microscopy and flow cytometry. While fluorescein demonstrated the highest signal outside the cell, among the four fluorophores, internalized Av-rhodamine green emitted the most light from SHIN3 ovarian cancer cells both in vitro and in vivo. The internalized Av-rhodamine green complex appeared to localize to the endoplasmic vesicles. Thus, among the four common green fluorescent dyes, rhodamine green is the brightest green fluorescence probe after cellular internalization. This information could have implications for the design of tumor-targeted fluorescent probes that rely on cellular internalization for cancer detection.     

量子点的近场激发荧光特性研究

近场光学显微镜具有nm量级的空间分辨率,量子点(quantum dots,QDs)荧光探针具有激发谱宽、发射谱线窄、荧光强度高、抗光漂白和稳定性高等优点,两者结合用于生物大分子的成像探测和识别具有广泛的应用前景。用近场光学显微镜对链霉亲和素偶联的QDs进行近场荧光激发,并对其荧光发射特性和光稳定性进行研究,结果表明:近场光学显微镜nm量级的空间分辨率,可以同时观察到了QDs的单体、二聚体和三聚体;QDs的荧光发射强度高,近场荧光像对比度好,单量子点的荧光半高宽达到25nm;对一定入射波长的单色激发光,QDs的近场荧光强度随着激发功率密度的增加线性增加,并很快趋于稳定。与传统的荧光染料如异硫氰酸荧光素相比,QDs的稳定性非常好,在激发功率密度为300W/cm2的近场辐射下,量子点的荧光强度超过6h基本保持不变,其抗光漂白能力远远高于普通荧光染料。     

Characterization and cancer cell targeted imaging properties of human antivascular endothelial growth factor monoclonal antibody conjugated CdTe/ZnS quantum dots

High luminescence quantum yield water‐soluble CdTe/ZnS core/shell quantum dots (QDs) stabilized with thioglycolic acid were synthesized. QDs were chemically coupled to fully humanized antivascular endothelial growth factor₁₆₅ monoclonal antibodies to produce fluorescent probes. These probes can be used to assay the biological affinity of the antibody. The properties of QDs conjugated to an antibody were characterized by ultraviolet and visible spectrophotometry, fluorescent spectrophotometry, sodium dodecyl sulfate–polyacrylamide gel electrophoresis, transmission electron microscopy and fluorescence microscopy. Cell‐targeted imaging was performed in human breast cancer cell lines. The cytotoxicity of bare QDs and fluorescent probes was evaluated in the MCF‐7 cells with an MTT viability assay. The results proved that CdTe/ZnS QD–monoclonal antibody nanoprobes had been successfully prepared with excellent spectral properties in target detections. Surface modification by ZnS shell could mitigate the cytotoxicity of cadmium‐based QDs. The therapeutic effects of antivascular endothelial growth factor antibodies towards cultured human cancer cells were confirmed by MTT assay. Copyright © 2014 John Wiley & Sons, Ltd.     

Intracellular delivery of quantum dot-protein cargos mediated by cell penetrating peptides

We utilize cell penetrating peptide functionalized QDs as specific vectors for the intracellular delivery of model fluorescent protein cargos. Multiple copies of two structurally diverse fluorescent proteins, the 27 kDa monomeric yellow fluorescent protein and the 240 kDa multichromophore b-phycoerythrin complex, were attached to QDs using either metal-affinity driven self-assembly or biotin-Streptavidin binding, respectively. Cellular uptake of these complexes was found to depend on the additional presence of cell-penetrating peptides within the QD-protein conjugates. Once inside the cells, the QD conjugates were mostly distributed within endolysosomal compartments, indicating that intracellular delivery of both QD assemblies was primarily driven by endocytotic uptake. Cellular microinjection of QD-fluorescent protein assemblies was also utilized as an alternate delivery strategy that could bypass the endocytic pathway. Simultaneous signals from both the QDs and the fluorescent proteins allowed verification of their colocalization and conjugate integrity upon delivery inside live cells. Due to their intrinsic fluorescence properties, this class of proteins provides a unique tool to test the ability of QDs functionalized with cell penetrating peptides to mediate the intracellular delivery of both small and large size protein cargos. Use of QD-peptide/fluorescent protein vectors may make powerful tools for understanding the mechanisms of nanoparticle-mediated drug delivery.     

Assembly and targeting of liposomal nanoparticles encapsulating quantum dots

Quantum dots (QDs) are attracting intense interest as fluorescence labeling agents for biomedical imaging because biocompatible coatings and relatively nontoxic rare earth metal QDs have emerged as possible options. QD photoemissions are bright, of narrow wavelength range, and very stable. We sought to encapsulate QDs within targeted PEGylated liposomes to reduce their propensity for liver uptake and to amplify the already strong QD emission signal. A novel lipid-QD conjugate initialized a process by which lipids in solution coalesced around the QDs. The liposomal structure was confirmed with size measurements, SEM, and IR spectroscopy. PEGylated QD liposomes injected into a xenograft tumor model largely cleared from the body within 24 h. Residual liver labeling was low. Targeted QD liposomes exhibited robust tumor labeling compared with controls. This study highlights the potential of these near IR emitting QD liposomes for preclinical/clinical applications.     

Synthesis of pheophorbide-a conjugates with anticancer drugs as potential cancer diagnostic and therapeutic agents

Pheophorbide-a, a chlorine based photosensitizer known to be selectively accumulated in cancer cells, was conjugated with anticancer drugs, doxorubicin and paclitaxel in the purpose of selective cancer diagnosis and therapy. Pheophorbide-a was conjugated with anticancer drugs via directly and by the use of selective cleavage linkers in cancer cell. The fluorescence of pheophorbide-a and doxorubicin conjugate by excitation at 420 or 440 nm was greatly diminished possibly by the energy transfer mechanism between two fluorescent groups. However, upon treatment in cancer cells, the conjugate showed to be cleaved to restore each fluorescence of pheophorbide-a and doxorubicin after 48 h of incubation. Also, pheophorbide-a conjugates either with doxorubicin and paclitaxel inhibited the growth of various cancer cells more potently than pheophorbide-a, which displayed very weak inhibitory activity. The results indicated that the pheophorbide-a conjugates with anticancer drugs could be utilized for selective cancer therapy as well as for the fluorescence detection of cancer.     

The deoxycholic acid targets miRNA-dependent CAC1 gene expression in multidrug resistance of human colorectal cancer

There is evidence indicating that bile acid is a promoter of colorectal cancer. Deoxycholic acid modifies apoptosis and proliferation by affecting intracellular signaling and gene expression. We are interested in revealing the relationship between deregulated miRNAs and deoxycholic acid in colorectal cancer development. We found that miR-199a-5p was expressed at a low level in human primary colonic epithelial cells treated with deoxycholic acid compared with control, and miR-199a-5p was significantly down-regulated in colorectal cancer tissues. The miR-199a-5p expression in colorectal cancer cells led to the suppression of tumor cell growth, migration and invasion. We further identified CAC1, a cell cycle-related protein expressed in colorectal cancer, as a miR-199a-5p target. We demonstrated that CAC1 is over-expressed in malignant tumors, and cellular CAC1 depletion resulted in cancer growth suppression. HCT-8 cells transfected with a miR-199a-5p mimic or inhibitor had a decrease or increase in CAC1 protein levels, respectively. The results of the luciferase reporter gene analysis demonstrated that CAC1 was a direct miR-199a-5p target. The high miR-199a-5p expression and low CAC1 protein expression reverse the tumor cell drug resistance. We conclude that miR-199a-5p can regulate CAC1 and function as a tumor suppressor in colorectal cancer. Therefore, the potential roles of deoxycholic acid in carcinogenesis are to decrease miR-199a-5p expression and/or increase the expression of CAC1, which contributes to tumorigenesis in patients with CRC. These findings suggest that miR-199a-5p is a useful therapeutic target for colorectal cancer.